
                                UPDATED SEQUENCE LISTING

<110> REGENERON PHARMACEUTICALS, INC.

<120> BIOLOGICALLY ACTIVE MACROLIDES, CONJUGATES THEREOF, AND 
      THERAPEUTIC USES
  
<130> 1550A-WO

<140> PCT/US14/29757      
<141> 2014-03-14          

<150> 61/792,216
<151> 2013-03-15

<160> 8

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic

<400> 1
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Pro Phe Ser Ser Tyr
            20                  25                  30          
Asp Met His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ser Ala Ile Gly Thr Ala Gly Ala Thr Tyr Tyr Pro Gly Ser Val Lys
    50                  55                  60                  
Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu
65                  70                  75                  80  
Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95      
Arg Gly Asp Tyr Val Trp Gly Thr Tyr Arg Pro Leu Phe Asp Tyr Trp
            100                 105                 110         
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120         

<210> 2
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic

<400> 2
Gly Phe Pro Phe Ser Ser Tyr Asp
 1               5              

<210> 3
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic

<400> 3
Ile Gly Thr Ala Gly Ala Thr
 1               5          

<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic

<400> 4
Ala Arg Gly Asp Tyr Val Trp Gly Thr Tyr Arg Pro Leu Phe Asp Tyr
 1               5                  10                  15      

<210> 5
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic

<400> 5
Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Trp Ala Ser Gln Gly Ile Asn Asn Tyr
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Tyr Ala Ala Ser Thr Leu Gln Thr Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Leu
                85                  90                  95      
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105         

<210> 6
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic

<400> 6
Gln Gly Ile Asn Asn Tyr
 1               5      

<210> 7
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic

<400> 7
Ala Ala Ser
 1          

<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic

<400> 8
Gln Gln Leu Asn Ser Tyr Pro Leu Thr
 1               5                  

